USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Rayence Co., Ltd.

USPTO PatentsView assignee record - 32 granted patents across 18 technology areas, recorded in grant years 2015–2023. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

RSS updates for this company

The verdict

According to USPTO PatentsView, Rayence ranks #9,855 of 49,997 tracked US assignees by granted-patent volume, with 32 patents across 18 technology areas.

#9,855
of 49,997 US assignees by volume
48th percentile
by Innovation Score (34.6/100)
10.5
avg claims per patent
-77%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R9855 · Foreign Corporation #9,855 · 32 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-PAR · TYPE-FRNCORP · VEL-DROP · BOOK-FULL

  • GRANTS-SMALL 32 grants
  • UPPER-Q #9,855/49,997
  • PHOTO-FINISH Promethean
  • CPC-FOCUS A61B · 18 areas
  • INNOV-THIN 34.6/100
  • CLAIMS-PAR 10.5 claims/avg
  • TYPE-FRNCORP Foreign Corp
  • VEL-DROP -77% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Promethean Limited (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Rayence’s 34.6 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Rayence

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Rayence's Innovation Score is 34.6/100 (48th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Rayence?

Each dot is one of Rayence’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Rayence’s own 10.5 claims/patent is at or below the 16.5 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Rayence vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 31.932.032.03232.032.032.1 10152025 Granted patents (volume) Avg claims / patent Promethean Limited - 32, 13.53PrometheanProtagonist Therapeutics, Inc. - 32, 18.69Protagonist Thera…Putco, Inc. - 32, 11.62PutcoQuidel Corporation - 32, 16.53QuidelRaytrx, LLC - 32, 20.19RaytrxREG Synthetic Fuels, LLC - 32, 20.88REG Synthetic Fue…Rieke Packaging Systems Limited - 32, 12.34Rieke Packaging S…Raindance Technologies, Inc. - 32, 19.94RaindanceRayence Co., Ltd. - 32, 10.53Rayence
Rayence vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Rayence's grants concentrate

Rayence Co., Ltd. is a focused PatentsView assignee: 18 CPC subclasses with 53.1% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2018 (9 grants) versus a trough of 1 in 2021. By volume, Rayence sits between Promethean Limited and Raindance Technologies, Inc..

Rayence's three-year grant acceleration

Rayence Co., Ltd. shows 2 grants in 2022–2024 against only 11 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at Rayence's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Rayence holds 32 patents at rank #9,853, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Rayence

By rank, the assignees closest to #9,853 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Rayence's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Rayence, neither rank-band nor same-CPC leaders (those blocks stay above). In A61B (Diagnosis), Rayence ranks #1,046 of 7,127 assignees by patent count in that subclass.

Rayence's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

35 48th percentile higher than 48% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

0246810 201520162017201820192020202120222023 1
USPTO utility patent grants by year · 2015–2023

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Rayence Co., Ltd. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 2 6.3%
2016 3 9.4%
2017 5 15.6%
2018 9 28.1%
2019 7 21.9%
2020 3 9.4%
2021 1 3.1%
2022 1 3.1%
2023 1 3.1%

Which technologies does Rayence Co., Ltd. patent most?

Top 15 of 18 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

Rayence Co., Ltd.'s patent record in context - here's where to go next.

  • Rayence Co., Ltd.'s lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 53.1% of its portfolio - see every assignee active in that class. Explore A61B
  • Ranked #9,855 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Rayence Co., Ltd. against Promethean Limited, an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 34.6/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.